Rivaroxaban is a direct oral Factor Xa inhibitor
anticoagulant. Its fixed-dose oral use without routine coagulation monitoring
has made it a high-volume generic API. ApiSyn produces it at its Ahmedabad,
India facility and provides specifications and COA on request.
| Chemical Name | 5-Chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl] methyl]-2-thiophenecarboxamide |
| Molecular Formula | C19H18ClN3O5S |
| Molecular Weight | 435.9 |
| CAS Number | 366789-02-8 |